4th Quarter - Report

COREWELL HEALTH for COREWELL HEALTH

Firm
Client
Income
—
Expenses
$60,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

2 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Discussions about Emergency Coronavirus Relief Act of 2020 and H.R. 133 Consolidated Appropriations Act, 2021. Discussions around the No Surprises Act. Discussions about COVID-19 Vaccine development, approval, and implementation. Discussions about the 340B Prescription Drug Program. Discussions about Telehealth payments during the pandemic and post-pandemic.

LobbyistCovered position, as disclosed
DAVID BILARDELLO —
PHILIP D YEITER —

Contacted: SENATE; HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Centers For Medicare and Medicaid Services (CMS)

Bills named: H.R. 133 (116th)

Medicare/Medicaid MMM

Discussions about Emergency Coronavirus Relief Act of 2020 and H.R. 133 Consolidated Appropriations Act, 2021. Discussions around the No Surprises Act. Discussions about COVID-19 Vaccine development, approval, and implementation. Discussions about the 340B Prescription Drug Program. Discussions about Telehealth payments during the pandemic and post-pandemic.

LobbyistCovered position, as disclosed
DAVID BILARDELLO —
PHILIP D YEITER —

Contacted: Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Centers For Medicare and Medicaid Services (CMS); SENATE

Bills named: H.R. 133 (116th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.